{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:15:44Z","timestamp":1788221744257,"version":"build-2803163510"},"reference-count":26,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:p>Multiple endocrine neoplasia type 2B (MEN2B) is a rare autosomal-dominant cancer predisposition syndrome in which prognosis is strongly influenced by the stage of medullary thyroid carcinoma at diagnosis. Virtually all affected children exhibit 1 or more extra-endocrine features during childhood, offering an opportunity for timely recognition. We retrospectively reviewed 5 pediatric patients with MEN2B managed at Bambino Ges\u00f9 Children\u2019s Hospital, all carrying the highest-risk RET proto-oncogene mutation (M918T); 4 cases were de novo and 1 was maternally inherited. In each case, genetic testing was prompted by extra-endocrine manifestations observed during infancy or early childhood, including chronic constipation, congenital clubfoot, and alacrimia. Recognition of these early clinical features led to genetic diagnosis before or at the onset of endocrine disease and enabled timely surgical management. This case series highlights the spectrum of extra-endocrine manifestations that may precede endocrine disease in MEN2B and emphasizes their value as early diagnostic clues. Early recognition of these features may facilitate prompt genetic testing and timely thyroidectomy before metastatic medullary thyroid carcinoma develops.<\/jats:p>","DOI":"10.1542\/peds.2025-075459","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:02:59Z","timestamp":1786492979000},"source":"Crossref","is-referenced-by-count":0,"title":["Extra-Endocrine Features in Infancy as Early Clues to MEN2B"],"prefix":"10.1542","volume":"158","author":[{"given":"Giulia","family":"Mirra","sequence":"first","affiliation":[{"name":"1Endocrinology and Diabetes Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Deodati","sequence":"additional","affiliation":[{"name":"1Endocrinology and Diabetes Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"},{"name":"2Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Grossi","sequence":"additional","affiliation":[{"name":"1Endocrinology and Diabetes Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Agolini","sequence":"additional","affiliation":[{"name":"3Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cappa","sequence":"additional","affiliation":[{"name":"4Research Area for Innovative Therapies in Endocrinopathies, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cianfarani","sequence":"additional","affiliation":[{"name":"1Endocrinology and Diabetes Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"},{"name":"2Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"},{"name":"5Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziamaria","family":"Ubertini","sequence":"additional","affiliation":[{"name":"1Endocrinology and Diabetes Unit, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"4","key":"2026083119561457300_r1","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","article-title":"Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B","volume":"91","author":"Carlson","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"2026083119561457300_r2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med."},{"key":"2026083119561457300_r3","doi-asserted-by":"crossref","first-page":"L39","DOI":"10.1530\/ERC-17-0122","article-title":"Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study","author":"Mathiesen","year":"2017","journal-title":"Endocr Relat Cancer."},{"issue":"6","key":"2026083119561457300_r4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid."},{"issue":"6","key":"2026083119561457300_r5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","article-title":"Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis","volume":"144","author":"Brauckhoff","year":"2008","journal-title":"Surgery."},{"issue":"3","key":"2026083119561457300_r6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2026083119561457300_r7","doi-asserted-by":"crossref","first-page":"e28056","DOI":"10.1002\/pbc.28056","article-title":"Multiple endocrine neoplasia type 2B: frequency of physical stigmata-results of the GPOH-MET registry","volume":"67","author":"Redlich","year":"2020","journal-title":"Pediatr Blood Cancer."},{"issue":"5","key":"2026083119561457300_r8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1530\/EJE-12-1106","article-title":"High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients","volume":"168","author":"Imai","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"2026083119561457300_r9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","article-title":"Multiple endocrine neoplasia type 2: a review","volume":"79","author":"Mathiesen","year":"2022","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"2026083119561457300_r10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/archsurg.1980.01380020012004","article-title":"Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications","volume":"115","author":"Block","year":"1980","journal-title":"Arch Surg."},{"issue":"2","key":"2026083119561457300_r11","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1002\/bjs.10746","article-title":"Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations","volume":"105","author":"Machens","year":"2018","journal-title":"Br J Surg."},{"issue":"1","key":"2026083119561457300_r12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-007-9665-4","article-title":"Failure to recognize multiple endocrine neoplasia 2B: more common than we think?","volume":"15","author":"Wray","year":"2008","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"2026083119561457300_r13","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/archinte.1992.00400180104016","article-title":"The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases","volume":"152","author":"Vasen","year":"1992","journal-title":"Arch Intern Med."},{"issue":"1","key":"2026083119561457300_r14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.10205","article-title":"Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course","volume":"94","author":"Leboulleux","year":"2002","journal-title":"Cancer."},{"issue":"12","key":"2026083119561457300_r15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00268-004-7637-4","article-title":"Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease","volume":"28","author":"Brauckhoff","year":"2004","journal-title":"World J Surg."},{"issue":"7","key":"2026083119561457300_r16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jpedsurg.2016.10.054","article-title":"Identification of intestinal ganglioneuromatosis leads to early diagnosis of MEN2B: role of rectal biopsy","volume":"52","author":"Gfroerer","year":"2017","journal-title":"J Pediatr Surg."},{"issue":"3","key":"2026083119561457300_r17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12020-021-02607-2","article-title":"Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series","volume":"72","author":"van den Broek","year":"2021","journal-title":"Endocrine."},{"issue":"3","key":"2026083119561457300_r18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrgastro.2017.149","article-title":"Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes","volume":"15","author":"Heuckeroth","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"2 Pt 1","key":"2026083119561457300_r19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.102.2.405","article-title":"Constipation as the presenting symptom in de novo multiple endocrine neoplasia type 2B","volume":"102","author":"de Krijger","year":"1998","journal-title":"Pediatrics."},{"issue":"4","key":"2026083119561457300_r20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.sempedsurg.2009.07.002","article-title":"The histopathology of gastrointestinal motility disorders in children","volume":"18","author":"Feichter","year":"2009","journal-title":"Semin Pediatr Surg."},{"issue":"5","key":"2026083119561457300_r21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00000658-200205000-00006","article-title":"Gastrointestinal manifestations of multiple endocrine neoplasia type 2","volume":"235","author":"Cohen","year":"2002","journal-title":"Ann Surg."},{"issue":"3","key":"2026083119561457300_r22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/2050640615611630","article-title":"Characteristics of chronic megacolon among patients diagnosed with multiple endocrine neoplasia type 2B","volume":"4","author":"Gibbons","year":"2016","journal-title":"United European Gastroenterol J."},{"issue":"6","key":"2026083119561457300_r23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/01676830.2019.1567800","article-title":"MEN 2B masquerading as chronic blepharitis and euryblepharon","volume":"38","author":"Huggins","year":"2019","journal-title":"Orbit."},{"issue":"3","key":"2026083119561457300_r24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2319\/042009-222.1","article-title":"Multiple endocrine neoplasia-2B presenting with orthodontic relapse","volume":"80","author":"Accurso","year":"2010","journal-title":"Angle Orthod."},{"issue":"9","key":"2026083119561457300_r25","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1210\/clinem\/dgaa296","article-title":"Pulmonary function in patients with multiple endocrine neoplasia 2B","volume":"105","author":"Fuller","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2026083119561457300_r26","doi-asserted-by":"crossref","first-page":"zsac166","DOI":"10.1093\/sleep\/zsac166","article-title":"Sleep dysregulation in sympathetic-mediated diseases: implications for disease progression","volume":"45","author":"Olivares","year":"2022","journal-title":"Sleep."}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-075459\/1951947\/pediatrics.2025075459.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2025-075459\/1951947\/pediatrics.2025075459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T23:56:19Z","timestamp":1788220579000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/158\/3\/e2025075459\/208540\/Extra-Endocrine-Features-in-Infancy-as-Early-Clues"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,8,12]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2025-075459","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"e2025075459"}}